MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.tranon.2021.101070

Медицинская библиотека · Translational oncology · 2021

Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs.

Moghanloo Ehsan, Mollanoori Hasan, Talebi Mohsen, Pashangzadeh Salar, Faraji Fatemeh, Hadjilooei Farimah, Mahmoodzadeh Habibollah

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Cell-based immunotherapies have been selected for the front-line cancer treatment approaches. Among them, CAR-T cells have shown extraordinary effects in hematologic diseases including chemotherapy-resistant acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL). In this approach, autologous T cells isolated from the patient's body genetically engineered to express a tumor specific synthetic receptor against a tumor antigen, then these cells expanded ex vivo and re-infusion back to the patient body. Recently, significant clinical response and high rates of complete remission of CAR T cell therapy in B-cell malignancies led to the approval of Kymriah and Yescarta (CD19-directed CAR-T cells) were by FDA for treatment of acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Despite promising therapeutic outcomes, CAR T cells also can elicit the immune-pathologic effects, such as Cytokine Release Syndrome (CRS), Tumor Lysis Syndrome (TLS), and on-target off-tumor toxicity, that hampered its application. Ineffective control of these highly potent synthetic cells causes discussed potentially life-threatening toxicities, so researchers have developed several mechanisms to remote control CAR T cells. In this paper, we briefly review the introduced toxicities of CAR-T cells, then describe currently existing control approaches and review their procedure, pros, and cons.

Для цитирования: Moghanloo Ehsan, Mollanoori Hasan, Talebi Mohsen, Pashangzadeh Salar, Faraji Fatemeh, Hadjilooei Farimah, Mahmoodzadeh Habibollah. Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs.. Translational oncology. 2021. DOI: 10.1016/j.tranon.2021.101070.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.